New Lilly Oncology President Selected

Anne White has been promoted to Senior Vice President of Lilly and President of Lilly Oncology.

Anne White has over 25 years of experience in the pharmaceutical industry and has held leadership positions in oncology, neuroscience, infectious disease drug development and process transformation. She also founded and led a startup company focused on the development of cancer drugs in partnership with the Moffitt Cancer Center and the National Cancer Institute. 

White joined Lilly in 1991 as an engineer, but has also worked in clinical research and cancer drug development. Prior to this recent promotion to Senior Vice President of Lilly and President of Lilly Oncology, White served as Vice President of portfolio management, Chorus and Next Generation R&D at Lilly.

Noted Chairman and Chief Executive Officer, David A. Ricks: "Anne brings a wealth of experience, expertise and leadership to our executive team. She has led and delivered against our Next Generation Development objectives, accelerating medicines to patients and playing a key role in our recent R&D productivity. Her experience leading significant change transformation within the company will be incredibly valuable as we look toward the future." 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.